Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds bacterium or component thereof or substance produced...
Reexamination Certificate
2007-10-31
2009-11-10
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds bacterium or component thereof or substance produced...
C424S009100, C424S009200, C424S130100, C424S164100, C424S184100, C424S234100, C424S248100, C435S004000, C435S007100, C435S007200, C435S007320, C435S007900, C435S007920
Reexamination Certificate
active
07615222
ABSTRACT:
The disclosed technology provides an enriched antibody population, highly specific for an antigen of a surface polysaccharide, from a mycobacterium. In a related embodiment, the antibody is enriched by having been raised in an environment that maintains antigenically active antigen. These antibodies may be used in an immunoreactive environment for detecting the presence of a mycobacterial infection in a sample from a subject.
REFERENCES:
patent: 5756327 (1998-05-01), Sassanfar et al.
patent: 6620785 (2003-09-01), Lambert, Jr.
patent: 2002/0034763 (2002-03-01), Glatman-Freedman et al.
patent: 2002/0103118 (2002-08-01), Lambert, Jr.
patent: 2004/0038201 (2004-02-01), Nau et al.
patent: 2006/0127406 (2006-06-01), Koulchin et al.
patent: WO 92/14155 (1992-08-01), None
patent: WO92/14155 (1992-08-01), None
patent: WO 97/26007 (1997-07-01), None
patent: WO 97/34149 (1997-09-01), None
patent: WO97/34149 (1997-09-01), None
patent: WO 01/64237 (2001-09-01), None
patent: WO 2006/012413 (2006-02-01), None
International Search Report: dated Jan. 4, 2006; received Jan. 5, 2006; PCT/US2005/025875.
Anderson, et al. “Specific Immune-Based Diagnosis of Tuberculosis,”The Lancet, vol. 356, Sep. 2000, pp. 1099-1104.
Apers, et al. “A Comparison of Direct Microscopy, the Concentration Method and the Mycobacteria Growth Indicator Tube for the Examination of Sputum for Acid-Fast Bacilli,”Int. J. Tuberc. Lung, 2003, pp. 376-381.
Bergmann, et al. “Clinical Evaluation of the Roche Amplicor PCR Mycobacterium Tuberculosis Test for Detection of M. Tuberculosis in Respiratory Specimens,”J. Clin. Microbiol., 1996, vol. 34, No. 5, pp. 1083-1085.
Boggian, et al. “Infrequent Detection of Lipoarabinomannan Antibodies in Human Immunodeficiency Virus-Associated Mycobacterial Disease,”J. Clin. Micbiol., Swiss HIV Cohort Study., vol. 34, No. 7, pp. 1854-1855, 1996.
Britton, W.J., et al. “Separate Antigenic Determinants on Cell Wall Associated Carbohydrate Antigens of Mycobacterium Ieprae Defined with Monoclonal Antibodies”International Journal of Leprosy and Other Mycobacterial Diseases, vol. 54, No. 4, Dec. 1986, pp. 545-555.
Burman, et al. “Clinical and Radiographic Features of HIV-related Tuberculosis,”Semin. Respir. Infect., vol. 18, No. 4, Dec. 2003, pp. 263-271.
Chan, et al. “Lipoarabinomannan, a Possible Virulence Factor Involved in Persistence of Mycobacterium Tuberculosis Within Macrophages,”Infect. Immun., 1991, Vo. 59, No. 5, pp. 1755-1761.
Daffe, et al. “The Envelope Layers of Mycobacteria with Reference to their Pathogenicity,”Adv. Microb. Physiol., 1998, vol. 39, pp. 131-203.
Doherty, et al. “Immune Responses to theMycobacterium Tuberculosis-Specific Antigen ESAT-6 Signal Subclinical Infection Among Contacts of Tuberculosis Patients,”J. Clin Microbiol., vol. 40, No. 2, Feb. 2002, pp. 704-706.
Doskeland, et al. “Bacterial Antigen Detection in Body Fluids: Methods for Rapid Antigen Concentration and Reduction of Nonspecific Reactions,”J. Clin. Microbiol., 1980, vol. 11, No. 4, pp. 380-384.
Elliot, et al. “Negative Sputum Smear Results in HIV-Positive Patients With Pulmonary Tuberculosis in Lusaka, Zambia,”Tuber. Lung Dis., vol. 74, 1993, pp. 191-194.
Githui, et al. “A Comparison Study on the Reliability of the Fluorescence Microscopy and Ziehl-Neelsen Method in the Diagnosis of Pulmonary Tuberculosis,”East Afr. Med. J., May 1993, pp. 263-266.
Hamasur, et al. “Rapid Diagnosis of Tuberculosis by Detection of Mycobacterial Lipoarabinomannan in Urine,”J. Microbiol. Methods, 2001, vol. 45, pp. 41-52.
Houston, et al. “The Association of Tuberculosis and HIV Infection in Harare, Zimbabwe,”Tuber. Lung Dis., vol. 75, 1994, pp. 220-226.
Hunter, et al. “Structure and Antigenicity of the Phosphorylated Lipopolysaccharide Antigens from the Leprosy and Tubercle Bacilli,”J. Biol. Chem., 1986, vol. 261, No. 26, pp. 2345-2351.
Johnson, et al. “Tuberculin-Purified Protein Derivative-, MPT-64-, and ESAT-6-Stimulated Gamma Interferon Responses in Medical Students Before and AfterMycobacterium BovisBCG Vaccination and in Patients with Tuberculosis,”Clin. Diagn Lab Immunol, vol. 6, No. 6, Nov. 1999, pp. 934-937.
Johnson, et al. “Impact of Human Immunodeficiency Virus Type-1 Infection on the Initial Bacteriologic and Radiographic Manifestations of Pulmonary Tuberculosis in Uganda,”Int. J. Tuberc. Lung Dis., 1997, pp. 397-404.
Jones, et al. “Relationship of the Manifestations of Tuberculosis to CD4 cell counts in patients with Human Immunodeficiency Virus Infection,”Am. Rev. Respir. Dis., vol. 148, 1993, pp. 1292-1297.
Karstaedt, et al. “The Bacteriology of Pulmonary Tuberculosis in a Population with High Human Immunodeficiency Virus Seroprevalance,”Int. J. Tuberc. Lung Dis., 1998, pp. 312-316.
Kramer, et al. “Delayed Diagnosis of Tuberculosis in Patients with Human Immunodeficiency Virus Infection,”Am. J. Med., 1990, vol. 89, pp. 451-456.
Lee, et al. “Mycobacterium Tuberculosis Cell Envelope,”Curr. Top Microbiol. Immunol., vol. 215, pp. 1-27, 1996.
Levy, et al. “A Reevaluation of Sputum Microscopy and Culture in the Diagnosis of Pulmonary Tuberculosis,”Chest, Jun. 1989, pp. 1193-1197.
Noordhoek, et al. “A Sensitivity and Specificity of PCR for Detection of Mycobacterium Tuberculosis: Blind Comparison Study Among Seven Laboratories,”J. Clin. Microbiol., 1994, vol. 32, No. 2, pp. 277-284.
Ong, et al. “A Molecular Epidemiological Assessment of Extrapulmonary Tuberculosis in San Francisco,”Clin. Infect. Dis., 2004, vol. 38, pp. 25-31.
Pereira, et al. “Development of Antigen Detection Assay for Diagnosis of Tuberculosis Using Sputum Samples,”J. Clin. Microbiol., vol. 38, No. 6, Jun. 2000, pp. 2278-2283.
Pollock, et al. “Specific Delayed-Type Hypersensitivity Responses to ESAT-6 Identify Tuberculosis-Infected Cattle,”J. Clin. Microbiol., vol. 41, No. 5, May 2003, pp. 1856-1860.
Pottumarthy, et al. “A Comparison of Seven Tests for Serological Diagnosis of Tuberculosis,”J. Clin. Microbiol., vol. 38, No. 6, Jun. 2000, pp. 2227-2231.
Rajalahti, et al. “Detection ofMycobacterium TuberculosisComplex in Sputum Specimens by the Automated Roche Cobas Amplicor Mycobacterium Tuberculosis Test,”J. Clin Microbiol., vol. 36, No. 4, Apr. 1998, pp. 975-978.
Range, et al. “Trend in HIV Prevalence Among Tuberculosis Patients in Tanzania,”Int. J. Tuberc. Lung Dis., 2001, pp. 405-412.
Ratanasuwan, et al. “Evaluation of the MycoDot Test for the Diagnosis of Tuberculosis in HIV Seropositive and Seronegative Patients,”Int. J. Tuberc. Lung Dis., 1997, pp. 259-264.
Ravn, et al. “Human T Cell Responses to the ESAT-6 Antigen from Mycobacterium Tuberculosis,”J. Infect. Dis., 1999, vol. 179, pp. 637-645.
Sada, et al. “Detection of Lipoarabinomannan as a Diagnosis Test for Tuberculosis,”J. Clin Microbiol., 1992, vol. 30, No. 9, pp. 2415-2418.
Sada, et al. “Evaluation of Lipoarabinomannan for the Serological Diagnosis of Tuberculosis,”J. Clin. Microbiol., 1990, vol. 28, No. 12, pp. 2587-2590.
Samb, et al. “Risk Factors for Negative Sputum Acid-Fast Bacilli Smears in Pulmonary Tuberculosis: Results from Dakar, Senegal, a City with Low HIV Seroprevalence.”Int. J. Tuberc. Lung Dis., 1999, pp. 330-336.
Schwebach, J.R., et al. “Expression of a Mycobacterium Tuberculosis Arabinomannan Antigen in Vitro and In Vivo,”Infection and Immunity, Sep. 2001, vol. 69, No. 9, pp. 5671-5678.
Swaminathan, et al. “Risk of Development of Tuberculosis in HIV-Infected Patients,”Int. J. Tuberc. Lung, 2000, pp. 839-844.
Tessema, et al. “Clinical and Radiological Features in Relation in Urinary Excretion of Lipoarabinomanna in Ethiopian Tuberculosis Patients,”Scand. J. Infect Dis.
Kerrick Jill L.
Koulchin Vladimir A.
Molokova Elena V.
Chemogen, Inc.
Sunstein Kann Murphy & Timbers LLP
Swartz Rodney P.
LandOfFree
Enriched antibody for detecting mycobacterial infection,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enriched antibody for detecting mycobacterial infection,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enriched antibody for detecting mycobacterial infection,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4144289